191 related articles for article (PubMed ID: 35739278)
21. Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
Cobaleda C; Godley LA; Nichols KE; Wlodarski MW; Sanchez-Garcia I
Cancer Discov; 2024 Mar; 14(3):396-405. PubMed ID: 38426560
[TBL] [Abstract][Full Text] [Related]
22. Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes.
Gillani R; Camp SY; Han S; Jones JK; Chu H; O'Brien S; Young EL; Hayes L; Mitchell G; Fowler T; Gusev A; Kamihara J; Janeway KA; Schiffman JD; Crompton BD; AlDubayan SH; Van Allen EM
Am J Hum Genet; 2022 Jun; 109(6):1026-1037. PubMed ID: 35512711
[TBL] [Abstract][Full Text] [Related]
23. Genetic predisposition to acute lymphoblastic leukemia: Overview on behalf of the I-BFM ALL Host Genetic Variation Working Group.
Kratz CP; Stanulla M; Cavé H
Eur J Med Genet; 2016 Mar; 59(3):111-5. PubMed ID: 26699264
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Germline Predisposition to Myeloid Neoplasms.
Thompson C; Ariagno S; Kohorst MA
Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of a germline ETV6 variant associated with inherited thrombocytopenia, acute lymphoblastic leukemia, and salivary gland carcinoma in childhood.
Yoshino H; Nishiyama Y; Kamma H; Chiba T; Fujiwara M; Karaho T; Kogashiwa Y; Morio T; Yan K; Bessho F; Takagi M
Int J Hematol; 2020 Aug; 112(2):217-222. PubMed ID: 32367453
[TBL] [Abstract][Full Text] [Related]
26. Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia-a case-control study.
Junk SV; Förster A; Schmidt G; Zimmermann M; Fedders B; Haermeyer B; Bergmann AK; Möricke A; Cario G; Auber B; Schrappe M; Kratz CP; Stanulla M
Leukemia; 2024 Apr; 38(4):887-892. PubMed ID: 38413718
[No Abstract] [Full Text] [Related]
27. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.
Pui CH; Nichols KE; Yang JJ
Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors.
Akhavanfard S; Padmanabhan R; Yehia L; Cheng F; Eng C
Nat Commun; 2020 May; 11(1):2206. PubMed ID: 32371905
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.
Yoshida M; Nakabayashi K; Yang W; Sato-Otsubo A; Tsujimoto SI; Ogata-Kawata H; Kawai T; Ishiwata K; Sakamoto M; Okamura K; Yoshida K; Shirai R; Osumi T; Kiyotani C; Shioda Y; Terashima K; Ishimaru S; Yuza Y; Takagi M; Arakawa Y; Imamura T; Hasegawa D; Inoue A; Yoshioka T; Ito S; Tomizawa D; Koh K; Matsumoto K; Kiyokawa N; Ogawa S; Manabe A; Niwa A; Hata K; Yang JJ; Kato M
Cancer Med; 2023 May; 12(10):11264-11273. PubMed ID: 37021926
[TBL] [Abstract][Full Text] [Related]
30. Germline ETV6 mutations and predisposition to hematological malignancies.
Feurstein S; Godley LA
Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
[TBL] [Abstract][Full Text] [Related]
31. NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.
Yoshida M; Nakabayashi K; Yang W; Sato-Otsubo A; Tsujimoto SI; Ogata-Kawata H; Kawai T; Ishiwata K; Sakamoto M; Okamura K; Yoshida K; Shirai R; Osumi T; Moriyama T; Nishii R; Takahashi H; Kiyotani C; Shioda Y; Terashima K; Ishimaru S; Yuza Y; Takagi M; Arakawa Y; Kinoshita A; Hino M; Imamura T; Hasegawa D; Nakazawa Y; Okuya M; Kakuda H; Takasugi N; Inoue A; Ohki K; Yoshioka T; Ito S; Tomizawa D; Koh K; Matsumoto K; Sanada M; Kiyokawa N; Ohara A; Ogawa S; Manabe A; Niwa A; Hata K; Yang JJ; Kato M
Blood Adv; 2021 Dec; 5(23):5420-5428. PubMed ID: 34662904
[TBL] [Abstract][Full Text] [Related]
32. Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk.
Usui Y; Iwasaki Y; Matsuo K; Endo M; Kamatani Y; Hirata M; Sugano K; Yoshida T; Matsuda K; Murakami Y; Maeda Y; Nakagawa H; Momozawa Y
Cancer Sci; 2022 Nov; 113(11):3972-3979. PubMed ID: 36065483
[TBL] [Abstract][Full Text] [Related]
33. Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients.
Wagener R; Brandes D; Jung M; Huetzen MA; Bergmann AK; Panier S; Picard D; Fischer U; Jachimowicz RD; Borkhardt A; Brozou T
Int J Cancer; 2024 Feb; 154(4):607-614. PubMed ID: 37776287
[TBL] [Abstract][Full Text] [Related]
34. KMT2A-D pathogenicity, prevalence, and variation according to a population database.
Larson JK; Hunter-Schlichting DN; Crowgey EL; Mills LJ; Druley TE; Marcotte EL
Cancer Med; 2023 Mar; 12(6):7234-7245. PubMed ID: 36479909
[TBL] [Abstract][Full Text] [Related]
35. Recurrent Germline Variant in
Schedel A; Friedrich UA; Morcos MNF; Wagener R; Mehtonen J; Watrin T; Saitta C; Brozou T; Michler P; Walter C; Försti A; Baksi A; Menzel M; Horak P; Paramasivam N; Fazio G; Autry RJ; Fröhling S; Suttorp M; Gertzen C; Gohlke H; Bhatia S; Wadt K; Schmiegelow K; Dugas M; Richter D; Glimm H; Heinäniemi M; Jessberger R; Cazzaniga G; Borkhardt A; Hauer J; Auer F
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563565
[TBL] [Abstract][Full Text] [Related]
36. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
[TBL] [Abstract][Full Text] [Related]
37. Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
Bandeira G; Rocha K; Lazar M; Ezquina S; Yamamoto G; Varela M; Takahashi V; Aguena M; Gollop T; Zatz M; Passos-Bueno MR; Krepischi A; Okamoto OK
Breast Cancer; 2021 Mar; 28(2):346-354. PubMed ID: 32986223
[TBL] [Abstract][Full Text] [Related]
38. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Li H; Sisoudiya SD; Martin-Giacalone BA; Khayat MM; Dugan-Perez S; Marquez-Do DA; Scheurer ME; Muzny D; Boerwinkle E; Gibbs RA; Chi YY; Barkauskas DA; Lo T; Hall D; Stewart DR; Schiffman JD; Skapek SX; Hawkins DS; Plon SE; Sabo A; Lupo PJ
J Natl Cancer Inst; 2021 Jul; 113(7):875-883. PubMed ID: 33372952
[TBL] [Abstract][Full Text] [Related]
39. Enrichment of heterozygous germline
Maciaszek JL; Oak N; Chen W; Hamilton KV; McGee RB; Nuccio R; Mostafavi R; Hines-Dowell S; Harrison L; Taylor L; Gerhardt EL; Ouma A; Edmonson MN; Patel A; Nakitandwe J; Pappo AS; Azzato EM; Shurtleff SA; Ellison DW; Downing JR; Hudson MM; Robison LL; Santana V; Newman S; Zhang J; Wang Z; Wu G; Nichols KE; Kesserwan CA
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31604778
[TBL] [Abstract][Full Text] [Related]
40. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]